Cerdelga Capsule
Product Images NDC 58468-0220

2 FDA label images from Genzyme Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cerdelga (NDC 58468-0220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cerdelga 01)

Chemical Structure (Cerdelga 01)
Chemical structure of eliglustat, the active ingredient in Cerdelga capsules. The image includes the molecular depiction of eliglustat and half a molecule of a second compound, likely representing a salt or hydrate form.*
FDA Label Image

Principal Display Panel (4 Blister Pack Carton)

Principal Display Panel (4 Blister Pack Carton)
Packaging label for Cerdelga (eliglustat) capsules, 84 mg strength. The label includes the proprietary name Cerdelga and generic name eliglustat, highlighting the 84 mg dosage per capsule. The labeler is Genzyme Corporation, and it notes this is a prescription drug with Rx Only. Additional packaging information, such as lot, expiration, and serial number fields, is visible along with storage conditions and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.